Titan Pharmaceuticals Receives FDA Communication On Ropinirole Implant Investigational New Drug Application February 27, 2017
Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2016 Financial Results November 3, 2016
Probuphine® Implant for Opioid Dependence Featured at 2016 International Society of Addiction Medicine Meeting October 28, 2016
Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2016 Financial Results August 3, 2016
Titan Pharmaceuticals Announces First Patients Treated With Probuphine(R) for Opioid Dependence June 20, 2016
